NCT07130565 · RECRUITING
Pan-Amyloid PET/CT in Various Amyloid-Related Disease
This trial is testing whether a special PET/CT imaging scan using radioactive tracers can detect amyloid deposits in patients with cardiac amyloidosis and other amyloid-related diseases. Cardiac amyloidosis is a condition where abnormal proteins build up in the heart. The phase is unspecified, so this appears to be an early feasibility or observational imaging study — not a treatment trial.
Eligibility criteria
Inclusion Criteria: - (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated cardiac amyloidosis (supporting evidence may include MRI, CT, serum markers and pathology report); (iii) patients who had scheduled Pan-Amyloid PET/CT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee. Exclusion Criteria: - (i) patients with non-CA lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-08-19